Regeneron Pharmaceuticals Inc. (REGN)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
30-Jan-23 4:11 PM
View: 
Brown Michael S
Director
Regeneron Pharmaceuticals I... (REGN) 27-Jan-23Option Exercise 1$520.01$520.01< 1%
12.91K to 12.91K
30-Jan-23 4:11 PM
View: 
Brown Michael S
Director
Regeneron Pharmaceuticals I... (REGN) 27-Jan-23Planned Option Sale 1$747.00$747.00(< 1%)
12.91K to 12.91K
10-Jan-23 4:03 PM
View: 
Brown Michael S
Director
Regeneron Pharmaceuticals I... (REGN) 06-Jan-23Planned Option Sale 3,070$747.14$2,293,720.00(19%)
15.98K to 12.91K
10-Jan-23 4:03 PM
View: 
Brown Michael S
Director
Regeneron Pharmaceuticals I... (REGN) 06-Jan-23Option Exercise 3,070$520.01$1,596,430.0024%
12.91K to 15.98K
05-Jan-23 4:21 PM
View: 
Bassler Bonnie L
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----15%
1.08K to 1.25K
05-Jan-23 4:20 PM
View: 
Poon Christine A
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----9%
1.87K to 2.04K
05-Jan-23 4:22 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Option Exercise 1,100$372.46$409,706.005%
22.22K to 23.32K
05-Jan-23 4:37 PM
View: 
Ryan Arthur F
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----< 1%
19.28K to 19.45K
05-Jan-23 4:21 PM
View: 
Brown Michael S
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----1%
12.74K to 12.91K
05-Jan-23 4:16 PM
View: 
Tessier-Lavigne Marc
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----7%
2.27K to 2.43K
05-Jan-23 4:15 PM
View: 
Zoghbi Huda Y
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----15%
1.08K to 1.25K
05-Jan-23 4:22 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Planned Option Sale 1,100$721.86$794,046.00(5%)
23.32K to 22.22K
05-Jan-23 4:15 PM
View: 
Coles N Anthony
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----15%
1.09K to 1.26K
05-Jan-23 4:14 PM
View: 
Thompson Craig B.
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 40----14%
0.28K to 0.32K
05-Jan-23 4:37 PM
View: 
Ryan Arthur F
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Sale (Planned) 100$726.29$72,628.80(< 1%)
19.45K to 19.35K
05-Jan-23 4:16 PM
View: 
Tessier-Lavigne Marc
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----7%
2.27K to 2.43K
05-Jan-23 4:19 PM
View: 
Sing George L
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----< 1%
28.2K to 28.36K
05-Jan-23 4:21 PM
View: 
Goldstein Joseph L
Director
Regeneron Pharmaceuticals I... (REGN) 03-Jan-23Grant 165----3%
6.08K to 6.25K
30-Dec-22 4:10 PM
View: 
Coles N Anthony
Director
Regeneron Pharmaceuticals I... (REGN) 28-Dec-22Option Exercise 5,758$442.24$2,546,410.00527%
1.09K to 6.85K
30-Dec-22 4:10 PM
View: 
Coles N Anthony
Director
Regeneron Pharmaceuticals I... (REGN) 28-Dec-22Planned Option Sale 5,758$714.11$4,111,820.00(84%)
6.85K to 1.09K
21-Dec-22 5:45 PM
View: 
Vagelos P Roy
Director
Regeneron Pharmaceuticals I... (REGN) 20-Dec-22Disposition 141$729.53$102,864.00(< 1%)
479.3K to 479.16K
20-Dec-22 4:06 PM
View: 
Fenimore Christopher R.
SVP Controller
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 1,926----7%
27.73K to 29.66K
20-Dec-22 4:07 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 2,973----15%
19.24K to 22.22K
20-Dec-22 4:07 PM
View: 
Larosa Joseph J
EVP General Counsel and Secret
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 2,752----10%
28.12K to 30.87K
20-Dec-22 4:08 PM
View: 
Murphy Andrew J
EVP Research
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 4,129----7%
60.91K to 65.04K
20-Dec-22 4:08 PM
View: 
Stahl Neil
EVP Research and Development
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 1,101----2%
62.42K to 63.52K
20-Dec-22 5:44 PM
View: 
Vagelos P Roy
Director
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 1,651----< 1%
477.65K to 479.3K
20-Dec-22 4:09 PM
View: 
van Plew Daniel P
EVP & General Mgr, Industrial
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 3,798----12%
31.15K to 34.95K
20-Dec-22 4:07 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 16-Dec-22Grant 3,853----13%
29.24K to 33.09K
13-Dec-22 4:13 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 12-Dec-22Sale (Planned) 264$730.17$192,765.00(1%)
19.51K to 19.24K
13-Dec-22 4:12 PM
View: 
Murphy Andrew J
EVP Research
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 492$753.28$370,614.00(< 1%)
61.4K to 60.91K
13-Dec-22 4:11 PM
View: 
Stahl Neil
EVP Research and Development
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 466$753.28$351,028.00(< 1%)
62.88K to 62.42K
13-Dec-22 4:12 PM
View: 
Vagelos P Roy
Director
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 57$753.28$42,937.00(< 1%)
477.7K to 477.65K
12-Dec-22 4:34 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 492$753.28$370,614.00(2%)
29.73K to 29.24K
13-Dec-22 4:09 PM
View: 
Fenimore Christopher R.
SVP Controller
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 247$753.28$186,060.00(< 1%)
27.98K to 27.73K
13-Dec-22 4:13 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 274$753.28$206,399.00(1%)
19.78K to 19.51K
13-Dec-22 4:12 PM
View: 
Larosa Joseph J
EVP General Counsel and Secret
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 492$753.28$370,614.00(2%)
28.61K to 28.12K
13-Dec-22 4:10 PM
View: 
van Plew Daniel P
EVP & General Mgr, Industrial
Regeneron Pharmaceuticals I... (REGN) 09-Dec-22Payment of Exercise 492$753.28$370,614.00(2%)
31.64K to 31.15K
12-Dec-22 4:35 PM
View: 
Bassler Bonnie L
Director
Regeneron Pharmaceuticals I... (REGN) 08-Dec-22Option Exercise 218$380.95$83,047.1020%
1.08K to 1.3K
12-Dec-22 4:34 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 08-Dec-22Option Exercise 3,000$381.92$1,145,760.0010%
28.99K to 31.99K
12-Dec-22 4:35 PM
View: 
Bassler Bonnie L
Director
Regeneron Pharmaceuticals I... (REGN) 08-Dec-22Planned Option Sale 218$779.00$169,822.00(17%)
1.3K to 1.08K
12-Dec-22 4:34 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 08-Dec-22Payment of Exercise 2,261$768.54$1,737,670.00(7%)
31.99K to 29.73K
02-Dec-22 4:05 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 02-Dec-22Planned Option Sale 610$756.66$461,564.00(2%)
29.6K to 28.99K
02-Dec-22 4:05 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 01-Dec-22Option Exercise 2,500$381.92$954,800.009%
28.99K to 31.49K
02-Dec-22 4:07 PM
View: 
Ryan Arthur F
Director
Regeneron Pharmaceuticals I... (REGN) 01-Dec-22Private Sale (Planned) 100$758.17$75,817.50(< 1%)
19.38K to 19.28K
02-Dec-22 4:05 PM
View: 
Landry Robert E
EVP Finance CFO
Regeneron Pharmaceuticals I... (REGN) 01-Dec-22Payment of Exercise 1,890$760.35$1,437,060.00(6%)
31.49K to 29.6K
02-Dec-22 4:06 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 01-Dec-22Option Exercise 1,100$372.46$409,706.006%
19.78K to 20.88K
02-Dec-22 4:06 PM
View: 
McCourt Marion
EVP Commercial
Regeneron Pharmaceuticals I... (REGN) 01-Dec-22Planned Option Sale 1,100$756.19$831,809.00(5%)
20.88K to 19.78K
25-Nov-22 1:07 PM
View: 
van Plew Daniel P
EVP & General Mgr, Industrial
Regeneron Pharmaceuticals I... (REGN) 23-Nov-22Option Sale 11,972$740.75$8,868,260.00(27%)
43.62K to 31.64K
25-Nov-22 1:07 PM
View: 
van Plew Daniel P
EVP & General Mgr, Industrial
Regeneron Pharmaceuticals I... (REGN) 22-Nov-22Payment of Exercise 38,028$741.81$28,209,600.00(47%)
81.64K to 43.62K